Cite Filings / VOR / 0000315066-25-001405
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Vor Biopharma Inc. · Filed 2025-05-12 · Acc 0000315066-25-001405

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-08-06 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-05-14 10-Q Quarterly Report
  • 2025-05-12 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-05-08 8-K Exit or restructuring costs · Executive or director change · Other events
  • 2025-05-07 4 PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
  • 2025-05-07 4 Chief Sci Off & Head Tech Ops gave up 876 shares (to pay taxes)
  • 2025-02-12 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Venrock Healthcare Capital Partners III, L.P. 9.9%
  2. 2026-11-16 SCHEDULE 13G/A · Chen Yu 9.2%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…